Correlation Between Tscan Therapeutics and Genocea Biosciences
Can any of the company-specific risk be diversified away by investing in both Tscan Therapeutics and Genocea Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tscan Therapeutics and Genocea Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tscan Therapeutics and Genocea Biosciences, you can compare the effects of market volatilities on Tscan Therapeutics and Genocea Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tscan Therapeutics with a short position of Genocea Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tscan Therapeutics and Genocea Biosciences.
Diversification Opportunities for Tscan Therapeutics and Genocea Biosciences
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Tscan and Genocea is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Tscan Therapeutics and Genocea Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Genocea Biosciences and Tscan Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tscan Therapeutics are associated (or correlated) with Genocea Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Genocea Biosciences has no effect on the direction of Tscan Therapeutics i.e., Tscan Therapeutics and Genocea Biosciences go up and down completely randomly.
Pair Corralation between Tscan Therapeutics and Genocea Biosciences
If you would invest (100.00) in Genocea Biosciences on November 3, 2024 and sell it today you would earn a total of 100.00 from holding Genocea Biosciences or generate -100.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 0.0% |
| Values | Daily Returns |
Tscan Therapeutics vs. Genocea Biosciences
Performance |
| Timeline |
| Tscan Therapeutics |
| Genocea Biosciences |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Tscan Therapeutics and Genocea Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Tscan Therapeutics and Genocea Biosciences
The main advantage of trading using opposite Tscan Therapeutics and Genocea Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tscan Therapeutics position performs unexpectedly, Genocea Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Genocea Biosciences will offset losses from the drop in Genocea Biosciences' long position.| Tscan Therapeutics vs. Apellis Pharmaceuticals | Tscan Therapeutics vs. Iteos Therapeutics | Tscan Therapeutics vs. Day One Biopharmaceuticals | Tscan Therapeutics vs. Acumen Pharmaceuticals |
| Genocea Biosciences vs. Chemours Co | Genocea Biosciences vs. The Cheesecake Factory | Genocea Biosciences vs. First Watch Restaurant | Genocea Biosciences vs. Cracker Barrel Old |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Complementary Tools
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |